Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Sterile, multi-dose Pfizer vial with 0.9% benzyl alcohol
Program sustained
AOD-9604 achieves selective fat metabolism by targeting beta-3 adrenergic receptors in adipose tissue without binding to growth hormone receptors that mediate IGF-1 production, glucose metabolism, and tissue growth
Systemic reactions may include gastrointestinal disturbances (nausea, diarrhea, abdominal cramps) when large doses are administered intravenously
later steps are held for at least four weeks as well
Efficient, respectful service
US$ 21.88
US$ 29.66
US$ 25.39
US$ 27.56
US$ 27.80
